In its upcoming report, Micron (MU) is predicted by Wall Street analysts to post quarterly earnings of $3.84 per share, reflecting an increase of 114.5% compared to the same period last year. Revenues are forecasted to be $12.57 billion, representing a year-over-year increase of 44.3%.The consensus EPS estimate for the quarter has undergone an upward revision of 3.6% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed their initial es ...

Novo Nordisk (NVO) closed the most recent trading day at $50.29, moving +2.53% from the previous trading session. The stock outpaced the S&P 500's daily gain of 0.21%. Elsewhere, the Dow gained 1.35%, while the tech-heavy Nasdaq lost 0.26%. Shares of the drugmaker have depreciated by 2.41% over the course of the past month, underperforming the Medical sector's gain of 3.7%, and the S&P 500's gain of 0.89%.The upcoming earnings release of Novo Nordisk will be of great interest to investors. On that day, Novo ...

Core Viewpoint - Boeing's recent earnings report showed a wider-than-expected loss, but revenues increased significantly year-over-year, indicating potential operational improvements despite ongoing challenges [2][4]. Financial Performance - The adjusted loss for Q3 2025 was $7.47 per share, worse than the expected loss of $3.68, but improved from a loss of $10.44 per share in the same quarter last year [2]. - Revenues reached $23.27 billion, exceeding the consensus estimate of $21.92 billion by 6.2% and representing a 30.4% increase from $17.84 billion in the previous year [4]. - The total backlog increased to $635.69 billion from $618.54 billion at the end of Q2 2025 [5]. Segment Performance - **Commercial Airplane Segment**: Revenues surged 49% year-over-year to $11.09 billion, driven by higher jet deliveries, although it incurred an operating loss of $5.35 billion, worsening from a loss of $4.02 billion a year ago. Boeing delivered 160 commercial planes, a 38% increase year-over-year [6]. - **Defense, Space & Security (BDS)**: Revenues grew 25% to $6.90 billion, with an operating income of $0.11 billion compared to a loss of $2.38 billion in the prior year. The backlog for this segment stood at $76 billion, with 20% from international clients [7]. - **Global Services**: Revenues increased by 10% to $5.37 billion, generating an operating income of $938 million, up 12% from the previous year [8]. Financial Condition - At the end of Q3 2025, Boeing had cash and cash equivalents of $6.17 billion and short-term investments of $16.81 billion, down from $13.80 billion and $12.48 billion respectively at the end of 2024 [9][10]. - Long-term debt decreased to $44.61 billion from $52.59 billion at the end of 2024. The operating cash outflow for the first nine months of 2025 was $0.27 billion, significantly improved from $8.63 billion in the same period of 2024 [10]. Market Sentiment - There has been a downward trend in estimates, with a consensus estimate shift of -82.03% in the past month, leading to a Zacks Rank of 4 (Sell) for Boeing [11][13]. - Boeing currently holds a strong Growth Score of A but lags in Momentum with a C and has an overall VGM Score of D, indicating challenges in the value investment strategy [12]. Industry Comparison - Boeing operates within the Zacks Aerospace - Defense industry, where competitor Textron has seen a 4.6% gain over the past month, reporting revenues of $3.6 billion, a 5.1% year-over-year increase [14].

Core Insights - Descartes Systems (DSGX) is expected to report quarterly earnings of $0.46 per share, reflecting a 9.5% increase year-over-year, with revenues forecasted at $182.56 million, an 8.2% increase from the previous year [1] Earnings Estimates - Changes in earnings estimates are crucial for predicting investor reactions to stock performance, with empirical studies showing a strong correlation between earnings estimate revisions and short-term stock price performance [2] - Analysts have maintained the consensus EPS estimate for the quarter over the past 30 days, indicating a reassessment of projections [1] Revenue Projections - Analysts project 'Revenues- Services' to reach $167.08 million, indicating an 11.6% year-over-year increase [4] - 'Revenues- License' is forecasted at $2.78 million, reflecting a 19.6% decrease from the same quarter last year [4] - The average prediction for 'Revenues- Professional services and other' is $13.10 million, showing a 16.2% decline year-over-year [4] Stock Performance - Shares of Descartes Systems have decreased by 8.4% over the past month, contrasting with a 0.4% increase in the Zacks S&P 500 composite [5] - The company holds a Zacks Rank of 3 (Hold), suggesting it is expected to perform in line with the overall market in the near future [5]

Core Viewpoint - Pagaya Technologies Ltd. (PGY) is expected to report strong third-quarter earnings, with revenues projected to increase significantly year-over-year, driven by growth in fee revenues and network volume [2][9]. Financial Performance - In Q2, PGY achieved total revenues and other income of $326 million, marking a 30% year-over-year increase, primarily due to higher fee revenues [2]. - The Zacks Consensus Estimate for Q3 revenues is $339 million, indicating a 31.9% year-over-year improvement [2][7]. - The earnings estimate for the upcoming quarter remains unchanged at 62 cents per share, reflecting a 40.9% growth from the same quarter last year [3][4]. Estimate Revision Trend - The earnings estimates for the current quarter have remained stable over the past 30 days, with no changes noted [4]. - The consensus estimate for network volume is $2.84 billion, which represents a 20.7% increase from the prior year [8]. Growth Strategy - Pagaya's growth strategy includes expanding product offerings, enhancing monetization of existing partnerships, and adding new enterprise lending partners, particularly large U.S. banks and auto captives [9][20]. - The company anticipates total revenues and other income for Q3 to be between $330 million and $350 million [9]. Valuation and Market Performance - PGY shares have outperformed the S&P 500 Index in Q3 but are considered expensive relative to the industry, with a trailing 12-month price/book (P/B) ratio of 4.19X compared to the industry average of 3.35X [13][16]. - While PGY trades at a premium to LendingClub, it is at a discount to LendingTree, which has a P/B of 5.97X [19]. Business Model Resilience - The company has diversified its business model beyond personal loans into auto lending and point-of-sale financing, which helps mitigate cyclical risks [20]. - Pagaya has established a network of over 135 institutional funding partners to support its asset-backed securities, enhancing liquidity and stability [21].

Core Viewpoint - FS KKR Capital (FSK) is expected to report a quarterly earnings per share (EPS) of $0.57, reflecting a 23% decline year-over-year, with revenues projected at $376.07 million, a decrease of 14.7% compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised upward by 0.4% in the last 30 days, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Forecast - Analysts predict 'Investment income- Fee income' to be $9.82 million, down 53.2% year-over-year [5]. - The estimate for 'Investment income- Dividend and other income' is $74.61 million, indicating a 16.6% increase from the previous year [5]. - 'Investment income- Paid-in-kind interest income' is expected to reach $49.79 million, reflecting a 24.6% decline year-over-year [5]. - 'Investment income- Interest income' is forecasted at $239.33 million, down 17.5% from the prior-year quarter [6]. Stock Performance - Over the past month, FS KKR Capital shares have returned -1.6%, while the Zacks S&P 500 composite has increased by 2.1% [6]. - Currently, FS KKR Capital holds a Zacks Rank 4 (Sell), suggesting potential underperformance relative to the overall market in the near future [6].

Core Insights - Verizon Communications Inc. reported strong third-quarter 2025 results with wireless service revenues of $21 billion, reflecting a year-over-year increase of 2.1% [1][4] - Adjusted earnings surpassed the Zacks Consensus Estimate, while total revenues fell short of expectations [1][4] Financial Performance - Net income for the quarter was $5.06 billion, or $1.17 per share, compared to $3.41 billion, or 78 cents per share, in the same quarter last year, driven by top-line growth and reduced operating expenses [3] - Total operating revenues increased by 1.5% to $33.82 billion, but missed the consensus estimate of $34.18 billion [4] - Adjusted earnings were $1.21 per share, slightly above the previous year's $1.19 per share [3] Segment Results - Consumer segment revenues rose by 2.9% year over year to $26.1 billion, exceeding estimates [5] - Business segment revenues declined by 2.8% to $7.14 billion due to lower wholesale and enterprise revenues, falling short of estimates [8] Subscriber Growth - Fixed wireless access net additions reached 261,000, bringing the total subscriber base to nearly 5.4 million, with a target of 8 to 9 million by 2028 [2] - Wireless retail postpaid churn was recorded at 1.12%, while retail postpaid phone churn was 0.91% [6] Operating Metrics - Operating income improved by 36.8% to $8.1 billion, with total operating expenses down by 6.2% to $25.72 billion [11] - Consolidated adjusted EBITDA increased to $12.77 billion, reflecting growth in wireless service revenue [11] Cash Flow and Guidance - Verizon generated $28 billion in net cash from operating activities for the first nine months of 2025, compared to $26.48 billion in the previous year [12] - For 2025, the company anticipates wireless service revenue growth of 2%-2.8% and adjusted EBITDA growth of 2.5%-3.5% [13]

Core Viewpoint - MercadoLibre (MELI) is expected to report quarterly earnings of $9.74 per share, a 24.4% increase year-over-year, with revenues projected at $7.19 billion, reflecting a 35.4% year-over-year growth [1]. Earnings Estimates - Over the past 30 days, the consensus EPS estimate has been adjusted downward by 2.5%, indicating a reassessment by analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions to the stock [3]. Revenue Projections - Analysts project 'Revenues- Fintech' at $3.22 billion, a 48.1% increase from the prior year [5]. - 'Revenues- Commerce' is expected to reach $4.08 billion, indicating a 30% year-over-year change [5]. - 'Geographic Revenue- Mexico' is estimated at $1.67 billion, reflecting a 45.7% increase [5]. - 'Geographic Revenue- Argentina' is forecasted to be $1.56 billion, a 51.5% increase [6]. - 'Geographic Revenue- Brazil' is projected at $3.92 billion, showing a 34.5% increase [6]. - 'Geographic Revenue- Fintech- Brazil' is expected to reach $1.50 billion, a 36.3% increase [7]. - 'Geographic Revenue- Other countries' is estimated at $293.12 million, reflecting a 32.6% increase [7]. - 'Geographic Revenue- Fintech- Argentina' is projected at $1.06 billion, indicating a 70.2% increase [8]. - 'Gross merchandise volume' is expected to be $16.20 billion, compared to $12.91 billion in the same quarter last year [9]. - 'Total payment volume' is projected to reach $71.07 billion, up from $50.69 billion year-over-year [9]. Stock Performance - Over the past month, MercadoLibre shares have declined by 13.8%, while the Zacks S&P 500 composite has increased by 1.3% [9].

Core Insights - WaFd, Inc. (WAFD) reported a fourth-quarter fiscal 2025 earnings per share of 72 cents, missing the Zacks Consensus Estimate of 75 cents, but reflecting a year-over-year increase of 1.4% [1][10] - The company's full-year earnings per share of $2.63 also fell short of the Zacks Consensus Estimate of $2.73, although it grew 5.2% year over year [3] Financial Performance - Quarterly net income available to common shareholders was $56.9 million, down 1% from the prior-year quarter, slightly above the estimate of $56.8 million [2] - Full-year net income available to common shareholders was $211.4 million, up 14% from the previous year, closely aligning with the estimate of $211.3 million [3] - Quarterly net revenues were $188.3 million, a slight decline from the prior-year quarter and missing the Zacks Consensus Estimate of $190.2 million [4] - Full-year net revenues totaled $725.5 million, a marginal increase from the previous year, but also missing the Zacks Consensus Estimate of $727.4 million [4] Interest Income and Expenses - Net interest income (NII) for the quarter was $169.9 million, down 1.7% year over year, while the net interest margin (NIM) increased by 9 basis points to 2.71% [5] - Total non-interest income rose 15.8% year over year to $18.4 million, exceeding the estimate of $18 million [5] - Total non-interest expenses were $107 million, a 1% decrease year over year, attributed to lower FDIC insurance premiums and other expenses [6] Asset Quality and Loans - As of September 30, 2025, net loans receivable were $20.09 billion, down 1% from the prior quarter, while total customer deposits increased marginally to $21.44 billion [8] - The allowance for credit losses was 1.04% of gross loans outstanding, up from 1.01% in the prior-year quarter, indicating a deterioration in credit quality [11] Share Repurchase Activity - In the reported quarter, WAFD repurchased 0.97 million shares at an average price of $29.74 per share [12] Market Position and Outlook - The company is expected to benefit from relatively higher interest rates and a solid balance sheet, although it faces challenges from a tough macroeconomic environment [13]

Core Viewpoint - Analysts forecast Abbott (ABT) to report quarterly earnings of $1.30 per share, reflecting a year-over-year increase of 7.4%, with anticipated revenues of $11.41 billion, marking a 7.3% increase compared to the previous year [1]. Earnings Estimates - The consensus EPS estimate has been adjusted downward by 0.1% over the past 30 days, indicating a reassessment by covering analysts [2]. - Changes in earnings estimates are crucial for predicting investor reactions, as empirical research shows a strong correlation between earnings estimate revisions and short-term stock performance [3]. Key Metrics Projections - Analysts estimate 'Net sales- Nutrition' to reach $2.20 billion, a year-over-year change of +6.3% [5]. - 'Net sales- Medical Devices- Diabetes Care' is projected at $2.04 billion, indicating an increase of +18.2% year over year [5]. - 'Net sales- Diagnostics' is expected to be $2.31 billion, reflecting a decrease of -4.4% from the previous year [5]. - 'Net sales- Established Pharmaceuticals' is estimated at $1.53 billion, showing a +9% change year over year [6]. - 'Net sales- Diagnostics- U.S.' is projected at $909.57 million, indicating a decline of -11.9% from the prior year [6]. - 'Geographic Revenue- U.S.' is expected to be $4.38 billion, with a year-over-year change of +4.3% [6]. - 'Geographic Revenue- International' is estimated at $7.02 billion, reflecting a +9.2% change year over year [7]. - 'Net sales- Nutrition- International' is projected to reach $1.23 billion, indicating a +9.8% change [7]. - 'Net sales- Nutrition- U.S.' is expected at $966.71 million, reflecting a +1.8% change [7]. - 'Net sales- Diagnostics- International' is forecasted at $1.40 billion, indicating a +1.3% change [8]. - 'Net sales- Medical Devices- Rhythm Management- U.S.' is projected at $325.63 million, reflecting a +13.1% change year over year [8]. - 'Net sales- Medical Devices- Rhythm Management- International' is expected to reach $339.38 million, indicating a +9.8% change year over year [9]. Stock Performance - Abbott shares have returned +0.5% over the past month, compared to the Zacks S&P 500 composite's +3.5% change, with a Zacks Rank 3 (Hold), suggesting that ABT is expected to mirror the overall market performance in the near future [9].